Focus: Viz.ai develops AI-powered healthcare image analysis software for clinical decision support across neurology, cardiovascular, respiratory, and ophthalmology indications. The company operates as a software-driven medical device player in the digital health/diagnostics space rather than traditional pharma.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Viz.ai to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship stroke detection software with 1 active trial; core neurology application in large addressable market.
Help build intelligence for Viz.ai
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Viz.ai's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Neurology expansion targeting ICH patient stratification and trial recruitment optimization.
Cardiovascular entry point with ECG analysis capability; addresses unmet diagnostic need in rare cardiology.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub